Summary | Bottom line: Legend Group's IPO should get a solid
reception, and Alibaba's separately listed drug and film units
should also perform well over the next few years as the Hong
Kong stock exchange gains popularity for China tech firms. A
pair of stories today are casting a spotlight on Hong Kong and
its future potential ...
youngchinabiz.com | 15 November 2015